All Courses
-
$279
New FDA Draft Guidance: A Risk-Based Approach to Monitoring Clinical InvestigationsSandra “SAM” SatherOn-Demand -
$279
-
$279
Clinical Quality Management Systems (QMS): Establishing a Practical & Compliant ProgramPenelope Przekop, MSQA, RQAP-GCPOn-Demand -
$279
The MHRA Data Integrity Guidance Clarified: What it Means for Industry & PatientsBetsy FallenOn-Demand -
$279
-
$279
-
$279
How FDA and MHRA Decide Which Drug Facilities to Inspect – and at What FrequencyJerry ChapmanOn-Demand -
$279
-
$199
